{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T18:48:00Z","timestamp":1792176480672,"version":"4.4.0"},"reference-count":33,"publisher":"SAGE Publications","issue":"1","license":[{"start":{"date-parts":[[2019,2,1]],"date-time":"2019-02-01T00:00:00Z","timestamp":1548979200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.sagepub.com\/page\/policies\/text-and-data-mining-license"}],"content-domain":{"domain":["journals.sagepub.com"],"crossmark-restriction":true},"short-container-title":["Population Health Management"],"published-print":{"date-parts":[[2019,2]]},"abstract":"<jats:p>\n                    The objective was to compare diagnosis rates representing developmental outcomes and medical complications between infants with intrauterine opioid exposures who did not receive pharmacologic treatment for neonatal abstinence syndrome at the time of birth and infants for whom no exposure to substances of abuse were detected. This retrospective, descriptive study included approximately 95% of Hamilton County, Ohio resident births in 2014 and 2015. Universal maternal drug test results, performed at the time of birth, were documented and linked to electronic health records representing pediatric primary and subspecialty follow-up care as well as urgent care, emergency care, and inpatient services provided by Cincinnati Children's Hospital Medical Center through 2017, when all children were at least 24 months old. Diagnosis rates were compared between drug exposure groups using chi-square tests. Among infants born at &gt;34 weeks gestation and without other complex clinical conditions, infants with subclinical opioid exposures (N\u2009=\u2009473) were more likely than infants with no drug exposures (N\u2009=\u200914,933) to be diagnosed with behavioral or emotional disorders (3.0% vs 1.1%,\n                    <jats:italic toggle=\"yes\">P<\/jats:italic>\n                    \u2009=\u20090.0008), developmental delay (15.6% vs 7.6%,\n                    <jats:italic toggle=\"yes\">P<\/jats:italic>\n                    \u2009&lt;\u20090.0001), speech disorder (10.1% vs 6.5%,\n                    <jats:italic toggle=\"yes\">P<\/jats:italic>\n                    \u2009=\u20090.001), or strabismus (3.4% vs 1.0%,\n                    <jats:italic toggle=\"yes\">P<\/jats:italic>\n                    \u2009&lt;\u20090.0001), and more likely to be exposed to the hepatitis C virus (6.8% vs 0.1%,\n                    <jats:italic toggle=\"yes\">P<\/jats:italic>\n                    \u2009&lt;\u20090.0001). Increased diagnosis rates among all opioid exposed infants, regardless of withdrawal severity, may warrant the additional allocation of resources for screening and follow-up. Awareness of the increased risk for certain developmental delays and medical conditions is critical to early intervention and treatment supporting improved outcomes.\n                  <\/jats:p>","DOI":"10.1089\/pop.2018.0016","type":"journal-article","created":{"date-parts":[[2018,6,12]],"date-time":"2018-06-12T11:23:37Z","timestamp":1528802617000},"page":"19-24","update-policy":"https:\/\/doi.org\/10.1177\/sage-journals-update-policy","source":"Crossref","is-referenced-by-count":48,"title":["Developmental Disorders and Medical Complications Among Infants with Subclinical Intrauterine Opioid Exposures"],"prefix":"10.1177","volume":"22","author":[{"given":"Eric S.","family":"Hall","sequence":"first","affiliation":[{"name":"University of Cincinnati College of Medicine"},{"name":"Perinatal Institute"},{"name":"Cincinnati Children's Hospital Medical Center"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer M.","family":"McAllister","sequence":"additional","affiliation":[{"name":"University of Cincinnati College of Medicine"},{"name":"Perinatal Institute"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Scott L.","family":"Wexelblatt","sequence":"additional","affiliation":[{"name":"University of Cincinnati College of Medicine"},{"name":"Perinatal Institute"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"179","published-online":{"date-parts":[[2019,2,4]]},"reference":[{"key":"e_1_3_2_2_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2012.3951"},{"key":"e_1_3_2_3_2","doi-asserted-by":"publisher","DOI":"10.1542\/peds.2011-3212"},{"key":"e_1_3_2_4_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ogc.2014.02.010"},{"key":"e_1_3_2_5_2","doi-asserted-by":"publisher","DOI":"10.1542\/peds.2013-3524"},{"key":"e_1_3_2_6_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra1600879"},{"key":"e_1_3_2_7_2","doi-asserted-by":"publisher","DOI":"10.1002\/cpt.958"},{"key":"e_1_3_2_8_2","doi-asserted-by":"publisher","DOI":"10.1017\/S0012162201001219"},{"key":"e_1_3_2_9_2","doi-asserted-by":"publisher","DOI":"10.1111\/apa.12210"},{"key":"e_1_3_2_10_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.earlhumdev.2007.01.013"},{"key":"e_1_3_2_11_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41372-018-0088-9"},{"key":"e_1_3_2_12_2","doi-asserted-by":"publisher","DOI":"10.1891\/0730-0832.35.5.277"},{"key":"e_1_3_2_13_2","first-page":"276","article-title":"Perinatal and developmental outcome of infants exposed to methadone in-utero","volume":"76","author":"Kaltenbach K","year":"1987","unstructured":"Kaltenbach K, , Finnegan LP. Perinatal and developmental outcome of infants exposed to methadone in-utero. NIDA Res Monogr, 1987; 76:276.","journal-title":"NIDA Res Monogr"},{"key":"e_1_3_2_14_2","doi-asserted-by":"publisher","DOI":"10.1177\/0009922814549545"},{"key":"e_1_3_2_15_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0022-3476(82)80115-7"},{"key":"e_1_3_2_16_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0022-3476(76)80822-0"},{"key":"e_1_3_2_17_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpeds.2017.12.009"},{"key":"e_1_3_2_18_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1651-2227.2003.tb00561.x"},{"key":"e_1_3_2_19_2","first-page":"4093","article-title":"Ocular comorbidities in children with neonatal abstinence syndrome","volume":"55","author":"Traband A","year":"2014","unstructured":"Traband A, , Lambert J, , Christiansen SP. Ocular comorbidities in children with neonatal abstinence syndrome. Invest Ophthalmol Vis Sci, 2014; 55:4093\u20134093.","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"e_1_3_2_20_2","doi-asserted-by":"publisher","DOI":"10.1542\/peds.2013-4036"},{"key":"e_1_3_2_21_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpeds.2014.10.004"},{"key":"e_1_3_2_22_2","doi-asserted-by":"publisher","DOI":"10.1007\/s10995-017-2414-9"},{"key":"e_1_3_2_23_2","doi-asserted-by":"publisher","DOI":"10.1089\/pop.2017.0184"},{"key":"e_1_3_2_24_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpeds.2015.11.039"},{"key":"e_1_3_2_25_2","first-page":"141","article-title":"Neonatal abstinence syndrome: assessment and management","volume":"2","author":"Finnegan LP","year":"1975","unstructured":"Finnegan LP, , Connaughton JFJr, , Kron RE, , Emich JP. Neonatal abstinence syndrome: assessment and management. Addict Dis, 1975; 2:141\u2013158.","journal-title":"Addict Dis"},{"key":"e_1_3_2_26_2","doi-asserted-by":"publisher","DOI":"10.1038\/jp.2017.70"},{"key":"e_1_3_2_27_2","doi-asserted-by":"publisher","DOI":"10.1542\/peds.2006-1231"},{"key":"e_1_3_2_28_2","unstructured":"Ohio Department of Health. Ohio public health data warehouse: Ohio resident live births (2006-present). http:\/\/publicapps.odh.ohio.gov\/EDW\/DataBrowser\/Browse\/OhioLiveBirths Accessed January25 2018."},{"key":"e_1_3_2_29_2","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2431-14-199"},{"key":"e_1_3_2_30_2","first-page":"65","article-title":"A simple sequentially rejective multiple test procedure","volume":"6","author":"Holm S","year":"1979","unstructured":"Holm S. A simple sequentially rejective multiple test procedure. Scand J Stat, 1979; 6:65\u201370.","journal-title":"Scand J Stat"},{"key":"e_1_3_2_31_2","doi-asserted-by":"publisher","DOI":"10.1097\/MPG.0b013e318258328d"},{"key":"e_1_3_2_32_2","doi-asserted-by":"publisher","DOI":"10.1186\/s12911-017-0439-z"},{"key":"e_1_3_2_33_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00392-016-1025-6"},{"key":"e_1_3_2_34_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.acap.2011.02.007"}],"container-title":["Population Health Management"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.sagepub.com\/doi\/full-xml\/10.1089\/pop.2018.0016","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1089\/pop.2018.0016","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1089\/pop.2018.0016","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,2]],"date-time":"2026-05-02T01:23:47Z","timestamp":1777685027000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/10.1089\/pop.2018.0016"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,2]]},"references-count":33,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,2]]}},"alternative-id":["10.1089\/pop.2018.0016"],"URL":"https:\/\/doi.org\/10.1089\/pop.2018.0016","relation":{},"ISSN":["1942-7891","1942-7905"],"issn-type":[{"value":"1942-7891","type":"print"},{"value":"1942-7905","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,2]]}}}